Arrowhead Pharmaceuticals Inc (ARWR)
23.78
-0.14
(-0.59%)
USD |
NASDAQ |
Apr 23, 16:00
23.77
-0.01
(-0.04%)
Pre-Market: 20:00
Arrowhead Pharmaceuticals Cash from Operations (Quarterly): -117.84M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -117.84M |
| September 30, 2023 | -25.26M |
| June 30, 2023 | -21.45M |
| March 31, 2023 | -31.67M |
| December 31, 2022 | -75.52M |
| September 30, 2022 | -68.74M |
| June 30, 2022 | -68.82M |
| March 31, 2022 | 62.73M |
| December 31, 2021 | -61.31M |
| September 30, 2021 | -24.03M |
| June 30, 2021 | -29.61M |
| March 31, 2021 | 263.87M |
| December 31, 2020 | -38.92M |
| September 30, 2020 | -11.26M |
| June 30, 2020 | -33.43M |
| March 31, 2020 | -27.58M |
| December 31, 2019 | -23.53M |
| September 30, 2019 | 13.81M |
| June 30, 2019 | 10.53M |
| March 31, 2019 | -19.59M |
| December 31, 2018 | 168.28M |
| September 30, 2018 | -2.680M |
| June 30, 2018 | -14.41M |
| March 31, 2018 | -15.44M |
| December 31, 2017 | -14.69M |
| Date | Value |
|---|---|
| September 30, 2017 | -9.204M |
| June 30, 2017 | -10.41M |
| March 31, 2017 | -14.33M |
| December 31, 2016 | 10.00M |
| September 30, 2016 | -10.18M |
| June 30, 2016 | -18.35M |
| March 31, 2016 | -14.75M |
| December 31, 2015 | -21.15M |
| September 30, 2015 | -12.02M |
| June 30, 2015 | -13.12M |
| March 31, 2015 | -16.37M |
| December 31, 2014 | -24.20M |
| September 30, 2014 | -10.92M |
| June 30, 2014 | -9.776M |
| March 31, 2014 | -7.698M |
| December 31, 2013 | -7.022M |
| September 30, 2013 | -5.394M |
| June 30, 2013 | -5.335M |
| March 31, 2013 | -4.467M |
| December 31, 2012 | -3.838M |
| September 30, 2012 | -4.588M |
| June 30, 2012 | -3.889M |
| March 31, 2012 | -4.158M |
| December 31, 2011 | -2.706M |
| September 30, 2011 | -1.663M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-117.84M
Minimum
Dec 2023
263.87M
Maximum
Mar 2021
-16.21M
Average
-27.58M
Median
Mar 2020
Cash from Operations (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -79.93M |
| Viking Therapeutics Inc | -17.64M |
| Akero Therapeutics Inc | -48.63M |
| 89bio Inc | -34.29M |
| Sagimet Biosciences Inc | -7.083M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 64.84M |
| Cash from Financing (Quarterly) | 0.267M |
| Free Cash Flow | -402.70M |
| Free Cash Flow Per Share (Quarterly) | -1.736 |
| Free Cash Flow to Equity (Quarterly) | -186.50M |
| Free Cash Flow to Firm (Quarterly) | -183.99M |
| Free Cash Flow Yield | -15.76% |